Coniferyl Alcohol
Loading...Coniferyl Alcohol Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
Do not use if tamper evident seal is broken or missing.
Store in cool, dry place.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
For temporary relief of chest congestion with constriction, headaches, sinus congestion, and rhinitis with discharge.
History
There is currently no drug history available for this drug.
Other Information
There are no additional details available for this product.
Sources
Coniferyl Alcohol Manufacturers
-
Bioactive Nutritional, Inc.
![Coniferyl Alcohol Liquid [Bioactive Nutritional, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Coniferyl Alcohol | Bioactive Nutritional, Inc.
10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.
-
Apotheca Company
Coniferyl Alcohol | Apotheca Company
DIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. Consult a physician for use in children under 12 years of age.
-
Deseret Biologicals, Inc.
Coniferyl Alcohol | Oceanside Pharmaceuticals
The usual dosage of pentoxifylline extended-release tablet form is one tablet (400 mg) three times a day with meals.
While the effect of pentoxifylline may be seen within 2 to 4 weeks, it is recommended that treatment be continued for at least 8 weeks. Efficacy has been demonstrated in double-blind clinical studies of 6 months duration.
Digestive and central nervous system side effects are dose related. If patients develop these effects it is recommended that the dosage be lowered to one tablet twice a day (800 mg/day). If side effects persist at this lower dosage, the administration of pentoxifylline extended-release tablet should be discontinued.
In patients with severe renal impairment (creatinine clearance below 30 mL/min) reduce dose to 400 mg once a day. Dosing information cannot be provided for patients with hepatic impairment.
![Coniferyl Alcohol (Coniferyl Alcohol,) Liquid [Apotheca Company]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=869be369-57c7-4cf5-bd91-c4fc475b408c&name=mm1.jpg)
![Coniferyl Alcohol Liquid [Deseret Biologicals, Inc.]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=c28cf3c3-8c13-46c6-a051-6de99db19882&name=pentox-100s-label.jpg)
Login To Your Free Account